Foundry Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-645,164
Closed -$9.62M 399
2018
Q3
$9.62M Buy
645,164
+1,023
+0.2% +$14.9K 0.37% 93
2018
Q2
$9.04M Sell
644,141
-112,551
-15% -$1.49M 0.37% 94
2018
Q1
$9.84M Sell
756,692
-1,000
-0.1% -$12.8K 0.42% 80
2017
Q4
$10.4M Sell
757,692
-7,487
-1% -$101K 0.43% 82
2017
Q3
$10M Sell
765,179
-1,357
-0.2% -$17.5K 0.4% 84
2017
Q2
$9.87M Buy
766,536
+286,324
+60% +$3.81M 0.4% 90
2017
Q1
$6.19M Sell
480,212
-341,006
-42% -$4.36M 0.26% 136
2016
Q4
$10.1M Hold
821,218
0.44% 68
2016
Q3
$12.1M Sell
821,218
-316
-0% -$4.78K 0.64% 36
2016
Q2
$12.5M Buy
+821,534
New +$11.6M 0.71% 21

Other funds holding MPT

Foundry Partners's MPT Position: Q4 2018 in Review

Foundry Partners sold out of Medical Properties Trust (MPT) in Q4 2018, closing a stake of 645,164 shares — an estimated $9.62M sold.

Foundry Partners first reported a position in MPT in Q2 2016 and held it in 10 quarters. The position peaked at $12.5M in Q2 2016. 419 funds tracked by Wall St. Rank hold MPT as of Q4 2018.

  • Foundry Partners reported no remaining Medical Properties Trust position as of Q4 2018 after selling out during the quarter.
  • Foundry Partners sold 645,164 Medical Properties Trust shares in Q4 2018, an estimated $9.62M.
  • Foundry Partners first reported a position in Medical Properties Trust in Q2 2016 and held it in 10 quarters.
  • Foundry Partners's Medical Properties Trust position peaked at $12.5M in Q2 2016.
  • 419 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2018.

Based on Foundry Partners's 13F filing for Q4 2018, filed 10 Jan 2019.